Skip to main content
. 2023 Feb 17;15(2):686. doi: 10.3390/pharmaceutics15020686

Figure 12.

Figure 12

Nanoparticle-based multimodality PET imaging. (A) The broad range of targeted ligands that may be conjugated to CLIO, including, but not limited, to 18F through click chemistry and peptides. Tumor-bearing mice were coinjected with a fluorescent peptide against integrins, a fluorescent cathepsin sensor, and 64Cu-CLIO-VT680, and then subjected to in vivo multichannel PET-CT (B) and FMT/PET-CT (C) [163].